
  
    
      
        Introduction_NNP
        With_IN the_DT increasing_VBG worldwide_NN availability_NN of_IN liver_NN
        transplantation_NN ,_, a_DT standardized_JJ assessment_NN of_IN severity_NN of_IN
        illness_NN is_VBZ needed_VBN to_TO evaluate_VB patient_NN outcome_NN objectively_RB
        over_IN time_NN and_CC between_IN different_JJ institutions_NNS ._.
        Cirrhosis-specific_NNP scoring_VBG systems_NNS ,_, such_JJ as_IN the_DT Child-_NNP Pugh_NNP
        classification_NN and_CC Show_NNP 's_POS risk_NN score_NN ,_, have_VBP been_VBN shown_VBN to_TO be_VB
        good_JJ predictors_NNS of_IN outcome_NN of_IN cirrhotic_JJ patients_NNS [_NN 1_CD ]_NN ._.
        However_RB ,_, when_WRB used_VBN as_IN predictors_NNS of_IN outcome_NN for_IN liver_NN
        transplantation_NN patients_NNS the_DT results_NNS are_VBP inconsistent_JJ [_NN 2_CD ,_,
        3_CD ,_, 4_CD ]_NN ._. This_DT is_VBZ partly_RB explained_VBN by_IN the_DT fact_NN that_IN the_DT
        preoperative_JJ condition_NN is_VBZ only_RB one_CD factor_NN in_IN a_DT series_NN of_IN
        complex_JJ interactions_NNS that_WDT include_VBP intra-operative_JJ and_CC
        postoperative_JJ factors_NNS ._. Systems_NNS for_IN predicting_VBG the_DT severity_NN
        of_IN illness_NN and_CC mortality_NN ,_, such_JJ as_IN the_DT Acute_NNP Physiology_NNP and_CC
        Chronic_NNP Health_NNP Evaluation_NNP (_( APACHE_NNP )_) II_NNP system_NN ,_, are_VBP
        attractive_JJ options_NNS for_IN this_DT group_NN because_IN they_PRP rely_VBP on_IN data_NNS
        collected_VBN soon_RB after_IN admission_NN to_TO the_DT intensive_JJ care_NN unit_NN
        (_( ICU_NNP )_) ,_, which_WDT is_VBZ likely_JJ to_TO reflect_VB preoperative_JJ ,_,
        intra-operative_JJ and_CC postoperative_JJ contributions_NNS ._.
        The_DT APACHE_NNP II_NNP system_NN was_VBD described_VBN by_IN Knaus_NNP 
        et_CC al_NN ._. in_IN 1985_CD to_TO predict_VB hospital_NN
        mortality_NN in_IN ICU_NNP patients_NNS [_NN 5_CD ]_NN ._. The_DT multiple_JJ logistic_JJ
        regression_NN equations_NNS were_VBD based_VBN on_IN data_NNS collected_VBN on_IN 5050_CD
        medical_JJ and_CC surgical_JJ patients_NNS admitted_VBN to_TO the_DT ICU_NNP in_IN 13_CD
        tertiary_JJ medical_JJ centers_NNS in_IN the_DT USA_NNP ._. This_DT outcome_NN
        prediction_NN system_NN has_VBZ been_VBN used_VBN to_TO evaluate_VB and_CC compare_VB the_DT
        performance_NN of_IN ICUs_NNP in_IN different_JJ hospitals_NNS and_CC countries_NNS ._.
        In_IN addition_NN to_TO general_JJ ICU_NNP patients_NNS ,_, APACHE_NNP II_NNP has_VBZ also_RB
        been_VBN studied_VBN in_IN specific_JJ groups_NNS of_IN patients_NNS such_JJ as_IN those_DT
        with_IN trauma_NN [_NN 6_CD ]_NN ,_, sepsis_NN [_NN 7_CD ]_NN ,_, and_CC cirrhosis_NNS [_NN 8_CD ]_NN ._.
        The_DT APACHE_NNP II_NNP prediction_NN equation_NN incorporates_VBZ three_CD
        variables_NNS :_: an_DT APACHE_NNP II_NNP score_NN ,_, the_DT diagnostic_JJ category_NN of_IN
        the_DT patient_NN ,_, and_CC whether_IN the_DT surgery_NN was_VBD emergency_NN or_CC
        elective_JJ ._. The_DT APACHE_NNP II_NNP score_NN consists_VBZ of_IN the_DT Acute_NNP
        Physiology_NNP Score_NN ,_, which_WDT is_VBZ calculated_VBN from_IN 14_CD physiologic_JJ
        variables_NNS that_WDT are_VBP scored_VBN from_IN 0_CD to_TO 4_CD and_CC depend_VB upon_IN the_DT
        degree_NN of_IN deviation_NN from_IN normal_JJ ._. Points_NNPS for_IN age_NN and_CC for_IN
        chronic_JJ illness_NN are_VBP also_RB assigned_VBN ._. There_EX are_VBP 50_CD different_JJ
        diagnostic_JJ categories_NNS ,_, each_DT with_IN a_DT different_JJ weight_NN used_VBN in_IN
        calculating_VBG the_DT predicted_VBN mortality_NN ._. There_EX is_VBZ no_DT specific_JJ
        diagnostic_JJ category_NN weight_NN for_IN liver_NN transplantation_NN ,_,
        because_IN there_EX were_VBD no_DT liver_NN transplantation_NN patients_NNS in_IN the_DT
        developmental_NN database_NN for_IN this_DT system_NN ._. Thus_RB ,_, when_WRB this_DT
        system_NN is_VBZ used_VBN for_IN postoperative_JJ liver_NN transplantation_NN
        patients_NNS ,_, the_DT diagnostic_JJ category_NN weight_NN '_'' postoperative_JJ
        other_JJ gastrointestinal_NN surgery_NN '_'' is_VBZ used_VBN ._. This_DT approach_NN has_VBZ
        been_VBN shown_VBN to_TO overestimate_NN mortality_NN significantly_RB [_NN 9_CD ]_NN ._.
        Angus_NNP 
        et_CC al_NN ._. recently_RB derived_VBD a_DT new_JJ
        diagnostic_JJ category_NN weight_NN based_VBN on_IN their_PRP$ population_NN of_IN
        liver_NN transplantation_NN patients_NNS [_NN 9_CD ]_NN ._. The_DT purpose_NN of_IN the_DT
        study_NN was_VBD to_TO validate_NN the_DT newly_RB derived_VBN postoperative_JJ
        orthotopic_JJ liver_NN transplantation_NN (_( OLTX_NNP )_) -_: specific_JJ diagnostic_JJ
        weight_NN for_IN APACHE_NNP II_NNP in_IN independent_JJ databases_NNS ._.
      
      
        Methods_NNP
        King_NNP Fahad_NNP National_NNP Guard_NNP Hospital_NNP (_( KFNGH_NNP )_) is_VBZ a_DT 550_CD -_: bed_NN
        tertiary_JJ care_NN center_NN ._. The_DT 12_CD -_: bed_NN medical-surgical_JJ ICU_NNP has_VBZ
        600_CD admissions_NNS per_IN year_NN ._. The_DT liver_NN transplantation_NN program_NN
        is_VBZ the_DT main_JJ program_NN in_IN the_DT Kingdom_NNP of_IN Saudi_NNP Arabia_NNP ._. The_DT
        University_NNP of_IN Wisconsin_NNP (_( UW_NNP )_) liver_NN transplantation_NN program_NN
        is_VBZ a_DT major_JJ program_NN in_IN the_DT USA_NNP ._. Liver_NNP transplantation_NN
        patients_NNS are_VBP admitted_VBN to_TO the_DT Trauma_NNP and_CC Life_NNP Support_NN
        Center_NNP ,_, which_WDT is_VBZ a_DT multidisciplinary_JJ ICU_NNP that_WDT admits_VBZ 2000_CD
        patients_NNS per_IN year_NN ._. Medical_JJ records_NNS of_IN liver_NN transplantation_NN
        patients_NNS admitted_VBN postoperatively_RB to_TO the_DT adult_JJ ICU_NNP in_IN the_DT
        period_NN April_NNP 1996_CD to_TO January_NNP 2000_CD at_IN KFNGH_NNP and_CC April_NNP 1997_CD
        to_TO January_NNP 2000_CD at_IN UW_NNP were_VBD reviewed_VBN ._. Re-transplantations_NNP ,_,
        kidney-liver_JJ and_CC living-related_JJ transplantations_NNS were_VBD
        excluded_VBN ._. The_DT following_VBG data_NN were_VBD collected_VBN :_: age_NN ,_, sex_NN ,_, and_CC
        underlying_VBG liver_NN disease_NN ._. APACHE_NNP II_NNP scores_NNS were_VBD calculated_VBN
        according_VBG to_TO the_DT original_JJ methodology_NN by_IN using_VBG the_DT worst_JJS
        physiologic_JJ values_NNS in_IN the_DT first_JJ ICU_NNP day_NN ._. The_DT only_JJ exception_NN
        was_VBD Glasgow_NNP Coma_NNP Score_NN (_( GCS_NNP )_) ._. Most_JJS of_IN these_DT patients_NNS were_VBD
        still_RB under_IN the_DT influence_NN of_IN postoperative_JJ sedation_NN during_IN
        the_DT first_JJ 24_CD hours_NNS in_IN ICU_NNP ,_, and_CC the_DT worst_JJS GCS_NNP would_MD reflect_VB
        the_DT effect_NN of_IN sedation_NN more_JJR than_IN the_DT true_JJ underlying_VBG mental_JJ
        status_NN ._. We_PRP therefore_RB used_VBD the_DT best_JJS GCS_NNP ,_, which_WDT we_PRP felt_VBD would_MD
        be_VB a_DT better_JJR reflection_NN of_IN the_DT patient_NN 's_POS mental_JJ status_NN ._. All_DT
        patients_NNS were_VBD given_VBN chronic_JJ health_NN points_NNS ._. Vital_NNP status_NN at_IN
        discharge_NN from_IN the_DT hospital_NN was_VBD registered_VBN ._.
        Predicted_NNP mortality_NN was_VBD calculated_VBN with_IN the_DT logistic_JJ
        regression_NN formula_NN described_VBD in_IN the_DT original_JJ article_NN [_NN 5_CD ]_NN ._.
        We_PRP used_VBD two_CD approaches_NNS :_: the_DT original_JJ APACHE_NNP II_NNP diagnostic_JJ
        category_NN weight_NN of_IN postoperative_JJ gastrointestinal_NN surgery_NN
        (_( -_: 0_CD ._. 613_CD )_) ,_, and_CC the_DT OLTX-specific_NNP diagnostic_JJ category_NN weight_NN
        calculated_VBN by_IN Angus_NNP 
        et_CC al_NN ._. (_( -_: 1_CD ._. 076_CD )_) [_NN 9_CD ]_NN ._. The_DT formulae_NN
        for_IN calculating_VBG predicted_VBN mortality_NN (_( risk_NN of_IN death_NN [_NN ROD_NNP ]_NN )_)
        are_VBP as_IN follows_VBZ :_:
        for_IN the_DT original_JJ approach_NN ,_, ln_NN (_( ROD_NNP /_NN 1_CD -_: ROD_NNP )_) =_SYM -_: 3_CD ._. 517_CD +_NN
        (_( APACHE_NNP II_NNP score_NN ×_NN 0_CD ._. 146_CD )_) -_: 0_CD ._. 613_CD ;_:
        for_IN the_DT new_JJ approach_NN ,_, ln_NN (_( ROD_NNP /_NN 1_CD -_: ROD_NNP )_) =_SYM -_: 3_CD ._. 517_CD +_NN
        (_( APACHE_NNP II_NNP score_NN ×_NN 0_CD ._. 146_CD )_) -_: 1_CD ._. 076_CD ._.
        Standardized_JJ mortality_NN ratio_NN (_( SMR_NNP )_) was_VBD calculated_VBN by_IN
        dividing_VBG observed_VBN mortality_NN by_IN the_DT predicted_VBN mortality_NN ._. The_DT
        95_CD %_NN confidence_NN intervals_NNS (_( CIs_NNP )_) for_IN SMRs_NNP were_VBD calculated_VBN by_IN
        regarding_VBG the_DT observed_VBN mortality_NN as_IN a_DT Poisson_NNP variable_NN ,_,
        then_RB dividing_VBG its_PRP$ 95_CD %_NN CI_NNP by_IN the_DT predicted_VBN mortality_NN [_NN 10_CD ]_NN ._.
        The_DT two_CD approaches_NNS were_VBD compared_VBN with_IN regard_NN to_TO calibration_NN
        (_( the_DT ability_NN to_TO provide_VB a_DT risk_NN estimate_NN corresponding_JJ to_TO
        the_DT observed_VBN mortality_NN )_) and_CC discrimination_NN (_( the_DT ability_NN of_IN
        the_DT predictive_JJ system_NN to_TO differentiate_VB survivors_NNS from_IN
        non-survivors_JJ )_) ._. The_DT calibration_NN of_IN both_DT systems_NNS was_VBD
        evaluated_VBN with_IN the_DT Hosmer-_NNP Lemeshow_NNP goodness-of-fit_JJ 
        C_NNP -_: statistic_NN [_NN 11_CD ]_NN ._. We_PRP calculated_VBD the_DT
        
        C_NNP -_: statistic_NN by_IN dividing_VBG the_DT study_NN
        population_NN into_IN six_CD equal_JJ groups_NNS with_IN increasing_VBG predicted_VBN
        mortality_NN to_TO ensure_VB an_DT adequate_JJ number_NN of_IN patients_NNS in_IN each_DT
        group_NN ._. Discrimination_NNP was_VBD tested_VBN by_IN 2_CD ×_NN 2_CD classification_NN
        matrices_NNS at_IN decision_NN criteria_NNS of_IN 10_CD %_NN ,_, 30_CD %_NN ,_, and_CC 50_CD %_NN ._.
        Receiver_NNP operating_VBG characteristic_JJ (_( ROC_NNP )_) curves_NNS were_VBD
        constructed_VBN as_IN a_DT measure_NN of_IN assessing_VBG discrimination_NN with_IN
        10_CD %_NN stepwise_NN increments_NNS in_IN predicted_VBD mortality_NN ._. The_DT two_CD
        curves_NNS were_VBD compared_VBN by_IN computing_VBG the_DT areas_NNS under_IN the_DT ROC_NNP
        curves_NNS [_NN 12_CD ,_, 13_CD ]_NN ._.
        The_DT patient_NN characteristics_NNS and_CC outcome_NN data_NNS from_IN the_DT
        two_CD participating_VBG institutions_NNS were_VBD compared_VBN ,_, to_TO evaluate_VB
        the_DT overall_JJ performance_NN of_IN the_DT system_NN between_IN the_DT two_CD
        hospitals_NNS ._. Continuous_NNP variables_NNS were_VBD expressed_VBN as_IN means_VBZ ±_NN
        SD_NNP ._. Categorical_NNP values_NNS were_VBD expressed_VBN in_IN absolute_JJ and_CC
        relative_JJ frequencies_NNS ._. All_DT categorical_JJ variables_NNS were_VBD
        analyzed_VBN by_IN the_DT χ_NN 2_CD test_NN ._. Non-parametric_NNP variables_NNS were_VBD
        compared_VBN by_IN Kruskal-_NNP Wallis_NNP test_NN ._. 
        P_NN values_NNS of_IN 0_CD ._. 05_CD or_CC less_JJR were_VBD
        considered_VBN significant_JJ ._. Minitab_NNP for_IN Windows_NNP (_( Release_NNP 12_CD ._. 1_LS ,_,
        Minitab_NNP Inc_NNP ._. )_) was_VBD used_VBN for_IN statistical_JJ analysis_NN ._.
      
      
        Results_NNS
        
          Patient_NNP characteristics_NNS
          During_IN the_DT study_NN period_NN 174_CD postoperative_JJ liver_NN
          transplantation_NN patients_NNS were_VBD admitted_VBN to_TO ICU_NNP ._. Patients_NNS '_POS
          characteristics_NNS ,_, underlying_VBG liver_NN disease_NN ,_, APACHE_NNP II_NNP
          scores_NNS ,_, and_CC predicted_VBD and_CC observed_VBD outcomes_NNS are_VBP shown_VBN in_IN
          Table_NNP 1_CD ._.
        
        
          Actual_JJ and_CC predicted_VBD hospital_NN mortality_NN
          rates_NNS
          The_DT mean_NN APACHE_NNP II_NNP score_NN was_VBD 13_CD ._. 96_CD ,_, with_IN an_DT SD_NNP of_IN
          5_CD ._. 76_CD ._. Observed_NNP mortality_NN was_VBD 5_CD ._. 75_CD %_NN ._. When_WRB the_DT original_JJ
          diagnostic_JJ weight_NN was_VBD used_VBN ,_, APACHE_NNP II_NNP significantly_RB
          overestimated_JJ mortality_NN (_( predicted_VBD mortality_NN 12_CD ._. 96_CD %_NN ,_, SMR_NNP
          0_CD ._. 44_CD ,_, 95_CD %_NN CI_NNP 0_CD ._. 22_CD -_: 0_CD ._. 80_CD )_) ._. When_WRB the_DT new_JJ diagnostic_JJ weight_NN
          was_VBD used_VBN ,_, the_DT system_NN provided_VBD a_DT closer_JJR estimate_NN of_IN
          mortality_NN (_( predicted_VBD mortality_NN 8_CD ._. 89_CD %_NN ,_, SMR_NNP 0_CD ._. 65_CD ,_, 95_CD %_NN CI_NNP
          0_CD ._. 31_CD -_: 1_CD ._. 16_CD )_) ._. Fig_NNP ._. 1_LS shows_VBZ actual_JJ and_CC predicted_VBD mortality_NN
          with_IN the_DT use_NN of_IN both_DT approaches_NNS in_IN the_DT whole_JJ cohort_NN
          classified_VBD according_VBG to_TO APACHE_NNP II_NNP score_NN ._.
        
        
          Calibration_NNP
          The_DT goodness-of-fit_JJ analysis_NN ,_, with_IN the_DT Hosmer-_NNP Lemeshow_NNP
          
          C_NNP -_: statistic_NN ,_, is_VBZ shown_VBN in_IN Table_NNP 2_CD ;_:
          the_DT new_JJ system_NN had_VBD better_JJR calibration_NN (_( original_JJ model_NN ,_, χ_NN
          2_CD =_SYM 11_CD ._. 06_CD ,_, 
          P_NN =_SYM 0_CD ._. 03_CD ;_: new_JJ model_NN ,_, χ_NN 2_CD =_SYM 5_CD ._. 92_CD ,_, 
          P_NN =_SYM 0_CD ._. 20_CD )_) ._.
        
        
          Discrimination_NNP
          Discrimination_NNP examined_VBN by_IN 2_CD ×_NN 2_CD classification_NN
          matrices_NNS showed_VBD an_DT improvement_NN with_IN the_DT new_JJ diagnostic_JJ
          category_NN weight_NN ._. This_DT was_VBD reflected_VBN by_IN the_DT higher_JJR overall_JJ
          correct_JJ classification_NN rate_NN at_IN the_DT three_CD examined_VBD
          decision_NN criteria_NNS (_( see_VB Table_NNP 3_LS )_) ._. Discrimination_NNP was_VBD also_RB
          tested_VBN by_IN ROC_NNP curves_NNS (_( Fig_NNP ._. 2_LS )_) :_: the_DT areas_NNS under_IN receiver_NN
          characteristic_JJ curves_NNS for_IN the_DT two_CD approaches_NNS were_VBD almost_RB
          identical_JJ (_( 0_CD ._. 740_CD and_CC 0_CD ._. 744_CD ,_, respectively_RB )_) ._.
        
        
          Comparison_NNP between_IN the_DT two_CD institutions_NNS
          Table_NNP 4_CD shows_VBZ the_DT characteristics_NNS of_IN patients_NNS on_IN the_DT
          basis_NN of_IN their_PRP$ institutions_NNS ._. Patients_NNS from_IN KFNGH_NNP were_VBD
          slightly_RB (_( but_CC significantly_RB )_) younger_JJR than_IN patients_NNS at_IN UW_NNP ._.
          Hepatitis_NNP C_NNP virus_NN was_VBD more_RBR common_JJ ,_, and_CC alcohol-related_JJ
          liver_NN disease_NN was_VBD less_RBR common_JJ ,_, as_IN an_DT underlying_VBG disease_NN
          in_IN patients_NNS in_IN KFNGH_NNP than_IN in_IN those_DT at_IN UW_NNP ._. APACHE_NNP II_NNP
          scores_NNS ,_, and_CC correspondingly_RB predicted_VBD mortalities_NNS ,_, were_VBD
          higher_JJR in_IN KFNGH_NNP patients_NNS ._. Despite_IN these_DT differences_NNS ,_, the_DT
          performances_NNS of_IN the_DT prediction_NN systems_NNS (_( the_DT old_JJ and_CC the_DT
          new_JJ models_NNS )_) were_VBD quite_RB similar_JJ in_IN the_DT two_CD hospitals_NNS as_IN
          reflected_VBN by_IN SMRs_NNP ._. The_DT new_JJ approach_NN provided_VBN more_RBR
          accurate_JJ estimates_NNS of_IN hospital_NN mortality_NN in_IN each_DT hospital_NN
          than_IN the_DT old_JJ model_NN ._.
        
      
      
        Discussion_NNP
        The_DT findings_NNS of_IN our_PRP$ study_NN can_MD be_VB summarized_VBD as_IN follows_VBZ :_:
        (_( 1_LS )_) APACHE_NNP II_NNP with_IN its_PRP$ original_JJ diagnostic_JJ category_NN weight_NN
        overestimated_JJ hospital_NN mortality_NN in_IN postoperative_JJ liver_NN
        transplantation_NN patients_NNS ;_: (_( 2_LS )_) when_WRB the_DT newly_RB derived_VBN
        OLTX-specific_NNP diagnostic_JJ category_NN weight_NN was_VBD applied_VBN ,_,
        mortality_NN prediction_NN ,_, discrimination_NN ,_, and_CC calibration_NN of_IN
        APACHE_NNP II_NNP improved_VBD ;_: (_( 3_LS )_) despite_IN differences_NNS in_IN the_DT patient_NN
        populations_NNS ,_, the_DT performance_NN of_IN the_DT old_JJ and_CC new_JJ models_NNS ,_, as_IN
        reflected_VBN by_IN SMRs_NNP ,_, was_VBD similar_JJ in_IN the_DT two_CD institutions_NNS ._.
        The_DT literature_NN evaluating_VBG APACHE_NNP II_NNP in_IN postoperative_JJ
        liver_NN transplantation_NN patients_NNS is_VBZ limited_VBN ._. Bein_NNP 
        et_CC al_NN ._. [_NN 14_CD ]_NN reviewed_VBD the_DT use_NN of_IN
        scoring_VBG systems_NNS in_IN 123_CD liver_NN transplantation_NN patients_NNS ._. In_IN
        their_PRP$ study_NN ,_, APACHE_NNP II_NNP scores_NNS were_VBD reported_VBN ;_: however_RB ,_, no_DT
        calculation_NN of_IN the_DT predicted_VBN mortality_NN was_VBD performed_VBN ._. The_DT
        study_NN showed_VBD that_IN APACHE_NNP II_NNP scores_NNS had_VBD good_JJ discrimination_NN
        as_IN reflected_VBN by_IN the_DT areas_NNS under_IN the_DT curves_NNS of_IN the_DT ROC_NNP
        curves_NNS ._. A_DT second_JJ study_NN by_IN Sawyer_NNP 
        et_CC al_NN ._. [_NN 15_CD ]_NN found_VBD that_DT mortality_NN
        correlated_JJ with_IN the_DT APACHE_NNP II_NNP score_NN ._. However_RB ,_, the_DT predicted_VBN
        mortality_NN was_VBD again_RB not_RB calculated_VBN ._.
        Angus_NNP 
        et_CC al_NN ._. [_NN 9_CD ]_NN recently_RB calculated_VBD the_DT
        predicted_VBN mortality_NN for_IN postoperative_JJ liver_NN transplantation_NN
        patients_NNS and_CC found_VBD that_IN APACHE_NNP II_NNP system_NN overestimated_JJ
        mortality_NN when_WRB the_DT original_JJ equation_NN was_VBD used_VBN (_( SMR_NNP 0_CD ._. 73_CD ,_,
        95_CD %_NN CI_NNP 0_CD ._. 58_CD -_: 0_CD ._. 99_CD )_) ._. This_DT is_VBZ consistent_JJ with_IN our_PRP$ findings_NNS ._.
        The_DT inaccuracy_NN of_IN APACHE_NNP II_NNP with_IN its_PRP$ original_JJ equation_NN
        probably_RB arises_VBZ from_IN several_JJ factors_NNS ._. The_DT developmental_NN
        database_NN of_IN APACHE_NNP II_NNP did_VBD not_RB have_VB liver_NN transplantation_NN
        patients_NNS ;_: the_DT use_NN of_IN the_DT system_NN with_IN the_DT original_JJ equation_NN
        for_IN liver_NN transplantation_NN patients_NNS therefore_RB essentially_RB
        assumes_VBZ that_IN the_DT weighted_JJ diagnostic_JJ category_NN for_IN liver_NN
        transplantation_NN would_MD be_VB the_DT same_JJ as_IN for_IN postoperative_JJ
        gastrointestinal_NN surgery_NN ._. In_IN this_DT study_NN we_PRP show_VBP ,_, as_IN shown_VBN
        previously_RB by_IN Angus_NNP 
        et_CC al_NN ._. [_NN 9_CD ]_NN ,_, that_IN this_DT assumption_NN is_VBZ
        not_RB accurate_JJ because_IN it_PRP leads_VBZ to_TO a_DT significant_JJ
        overestimation_NN of_IN mortality_NN ._.
        We_PRP believe_VBP that_IN the_DT reason_NN is_VBZ related_VBN to_TO the_DT unique_JJ
        patho-physiology_JJ of_IN the_DT period_NN after_IN liver_NN transplantation_NN ._.
        Marked_NNP changes_NNS occur_VBP during_IN the_DT procedure_NN ,_, especially_RB at_IN
        the_DT time_NN of_IN reperfusion_NN [_NN 16_CD ,_, 17_CD ]_NN ._. These_DT include_VBP a_DT
        significant_JJ decrease_NN in_IN blood_NN pressure_NN ,_, a_DT decrease_NN in_IN
        systemic_JJ vascular_NN resistance_NN ,_, an_DT increase_NN in_IN cardiac_JJ
        output_NN ,_, a_DT decrease_NN in_IN pH_NN ,_, an_DT increase_NN in_IN lactate_NN ,_, an_DT
        increase_NN in_IN potassium_NN ,_, and_CC a_DT prolongation_NN of_IN prothrombin_NN
        time_NN [_NN 16_CD ,_, 17_CD ]_NN ._. Although_IN some_DT of_IN these_DT abnormalities_NNS start_VBP
        to_TO normalize_VB during_IN the_DT final_JJ stages_NNS of_IN surgery_NN ,_, some_DT will_MD
        persist_VB into_IN to_TO the_DT immediate_JJ postoperative_JJ period_NN [_NN 16_CD ]_NN
        and_CC will_MD be_VB reflected_VBN on_IN any_DT severity_NN of_IN illness_NN score_NN such_JJ
        as_IN APACHE_NNP II_NNP ._. These_DT changes_NNS start_VBP to_TO normalize_VB rapidly_RB as_IN
        the_DT graft_NN starts_VBZ to_TO function_VB ._. The_DT multitude_NN of_IN the_DT
        abnormalities_NNS and_CC the_DT speed_NN with_IN which_WDT they_PRP are_VBP corrected_VBN
        make_VB this_DT group_NN of_IN patients_NNS unique_JJ and_CC explains_VBZ the_DT
        inaccuracy_NN of_IN APACHE_NNP II_NNP when_WRB using_VBG the_DT diagnostic_JJ category_NN
        weight_NN of_IN '_POS postoperative_JJ gastrointestinal_NN surgery_NN '_'' ._.
        On_IN the_DT basis_NN of_IN the_DT above_JJ ,_, it_PRP is_VBZ not_RB surprising_VBG that_IN a_DT
        model_NN developed_VBN on_IN a_DT population_NN of_IN liver_NN transplant_NN
        patients_NNS would_MD provide_VB more_RBR accurate_JJ and_CC reproducible_JJ
        estimates_NNS ._. Similar_JJ disease-specific_JJ customizations_NNS of_IN
        mortality_NN prediction_NN systems_NNS have_VBP been_VBN performed_VBN ,_, such_JJ as_IN
        for_IN sepsis_NN [_NN 18_CD ]_NN ._.
        There_EX are_VBP several_JJ obvious_JJ advantages_NNS to_TO the_DT use_NN of_IN
        APACHE_NNP II_NNP as_IN a_DT model_NN of_IN severity_NN of_IN illness_NN for_IN liver_NN
        transplant_NN patients_NNS ._. These_DT include_VBP the_DT familiarity_NN with_IN the_DT
        system_NN and_CC its_PRP$ widespread_JJ use_NN in_IN ICUs_NNP ._. ICUs_NNP that_DT use_NN APACHE_NNP
        II_NNP as_IN their_PRP$ database_NN severity_NN of_IN illness_NN scoring_VBG system_NN
        will_MD find_VB it_PRP easy_JJ to_TO apply_VB the_DT system_NN to_TO this_DT subgroup_NN of_IN
        patients_NNS rather_RB than_IN implementing_VBG a_DT special_JJ
        disease-specific_JJ system_NN exclusively_RB for_IN OLTX_NNP patients_NNS ._. In_IN
        general_JJ ,_, using_VBG a_DT system_NN for_IN scoring_VBG the_DT severity_NN of_IN illness_NN
        is_VBZ essential_JJ for_IN monitoring_VBG transplant_NN program_NN performance_NN
        over_IN time_NN and_CC between_IN different_JJ institutions_NNS ._. Such_JJ a_DT system_NN
        also_RB can_MD be_VB useful_JJ for_IN grouping_VBG patients_NNS in_IN clinical_JJ
        studies_NNS ._.
        In_IN conclusion_NN ,_, APACHE_NNP II_NNP provided_VBD an_DT accurate_JJ estimate_NN
        of_IN mortality_NN in_IN liver_NN transplant_NN patients_NNS when_WRB the_DT
        OLTX-specific_NNP diagnostic_JJ category_NN weight_NN was_VBD used_VBN ._.
      
      
        Key_JJ messages_NNS
        ·_NN APACHE_NNP II_NNP with_IN its_PRP$ original_JJ diagnostic_JJ category_NN weight_NN
        overestimated_JJ hospital_NN mortality_NN in_IN postoperative_JJ liver_NN
        transplantation_NN patients_NNS ._.
        ·_NN When_WRB the_DT newly_RB derived_VBN OLTX_NNP specific_JJ diagnostic_JJ
        category_NN weight_NN was_VBD applied_VBN ,_, mortality_NN prediction_NN ,_,
        discrimination_NN and_CC calibration_NN of_IN APACHE_NNP II_NNP improved_VBD ._.
        ·_NN Despite_IN differences_NNS in_IN the_DT patient_NN population_NN ,_, the_DT
        performance_NN of_IN the_DT old_JJ and_CC new_JJ models_NNS was_VBD similar_JJ in_IN the_DT
        two_CD institutions_NNS as_IN reflected_VBN by_IN SMRs_NNP ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        APACHE_NNP =_SYM Acute_NNP Physiology_NNP and_CC Chronic_NNP Health_NNP Evaluation_NNP ;_:
        CI_NNP =_SYM confidence_NN interval_NN ;_: GCS_NNP =_SYM Glasgow_NNP Coma_NNP Score_NN ;_: ICU_NNP =_SYM
        intensive_JJ care_NN unit_NN ;_: OLTX_NNP =_SYM orthotopic_JJ liver_NN
        transplantation_NN ;_: ROC_NNP =_SYM receiver_NN operating_VBG characteristic_JJ ;_:
        SMR_NNP =_SYM standardized_JJ mortality_NN ratio_NN ._.
      
    
  
